Pharmaceutical Investing

Aequus Receives Encouragement from FDA for AQS1301 Development Path

Pharmaceutical Investing

AzurRx Enrolls Sixth Patient of Phase IIa Trial

Pharmaceutical Investing

Nick Dinsmoor of VirtualArmour: There are no Shortcuts When it Comes to Cybersecurity

Defense And Security Investing

Cardiome Shares Takes a Hit Following FDA Denial

Pharmaceutical Investing

CURE Pharmaceutical Subsidiary Completes Critical Milestone

Pharmaceutical Investing

Teligent Receives Fourth FDA Approval on 2017

Pharmaceutical Investing

Revive Therapeutics Appoints Scientific Advisor for Cannabinoid-Based Therapeutics

Cannabis Investing News

OncBioMune Submits Documents to Commercialize Norepinefrine in Mexico

Pharmaceutical Investing

Insys Settles For $4.5 Million with Illinois Due to Opioids Lawsuit

Pharmaceutical Investing

Ovid Therapeutics Announces First Patient Randomized in Clinical Trial

Pharmaceutical Investing

VistaGen Therapeutics Expands VistaStem's Scientific Advisory Board

Pharmaceutical Investing

GT Biopharma Announces Reverse Stock Split

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES